Background and aims: Only a few antimicrobials are effective against H. pylori, and antibiotic
resistance is an increasing problem for eradication therapies. In 2017, the World Health …

Background Ovarian cancer is one of the most prevalent cancers with a high mortality rate in
women. Published studies indicate that inflammation, DNA damage, and pelvic inflammatory …

Current management of gastric inflammation involves the eradication of Helicobacter pylori.
However, the effectiveness of commonly used antibiotics against H. pylori infection has …

Background Helicobacter pylori is a pathogenic bacteria that colonize the gastrointestinal
tract from human stomachs and causes diseases including gastritis, peptic ulcers, gastric …

Abstract Background The burden of Helicobacter pylori-induced gastric cancer varies based
on predominant H. pylori population in various geographical regions. Vietnam is a high H …

Background Helicobacter pylori (H. pylori) is a common pathogen in development of peptic
ulcers with pyroptosis. Rabeprazole, a critical component of standard triple therapy, has …

Helicobacter pylori, a Gram-negative microaerobic bacteria belonging to the phylum
Proteobacteria, can colonize in the stomach and duodenum, and cause a series of …

Helicobacter pylori is a gram-negative, intracellular, microaerophilic bacteria which causing
Peptic ulcer. This bacterium can change its shape which helps the bacteria to survive in the …

The stomach's colonization by Helicobacter pylori (H. pylori) results in gastritis, ulcers, and
stomach cancer. Frequently, pain is treated with medication, but resistant H. pylori infections …

摘要目的: 探寻幽门螺杆菌(Helicobacter pylori, Hp) 铁摄取调节蛋白(ferric uptake regulator,
Fur) 基因单核苷酸多态性(single nucleotide polymorphism, SNP) 和进化分型与胃癌的相关性 …